Amsterdam Public Health
-
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives
Schnyder, J. L., de Jong, H. K., Bache, E. B., van Hest, R. M., Schlagenhauf, P., Borrmann, S., Hanscheid, T. & Grobusch, M. P., 1 Mar 2023, In: Travel medicine and infectious disease. 52, p. 102520 102520.Research output: Contribution to journal › Article › Academic › peer-review
- All publications